Risk of bias assessment in included studies
EPOC criteria for randomised controlled trials and controlled before-and-after studies | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Study No | Reference | Adequate sequence generation | Adequate concealment of allocation | Similar baseline outcome measures | Similar baseline characteristics | Adequate follow-up | Blinding of outcome measures | Adequate protection against contamination | Free from selective outcome reporting | Free from other risks of bias | – |
1 | Chambliss et al23 | ? | + | ? | + | − | + | + | + | + | |
2 | Law and Lam24 | + | + | ? | + | + | + | + | + | + | |
3 | Bernitz et al25,26 | + | + | ? | + | + | + | + | + | + | |
4 | Hofmeyr et al27 | − | − | ? | ? | + | + | + | + | + | |
Newcastle-Ottawa Scale and STROBE quality assessment tool for cohort studies | |||||||||||
Study No | Reference | Representativeness* | Selection of the controls* | Ascertainment of exposure* | Outcomes not present at the start* | Comparability for parity* | Assessment of outcome* | Follow-up duration* | Adequate follow-up* | All outcome measures reported† | Authors discuss sources of bias† |
5 | Homer et al28 | + | + | + | + | − | + | + | + | + | − |
6 | Rana et al29 | + | + | + | + | − | + | + | + | + | + |
7 | Eide et al30‡ | + | + | + | ? | NA | ? | + | + | + | − |
8 | Suzuki et al31, Suzuki32 | + | + | + | + | + | + | + | + | + | − |
9 | Cheung et al33 34 | + | + | + | − | − | − | + | + | + | + |
10 | Brocklehurst et al35; Schroeder et al36 | + | + | + | + | + | + | + | + | + | + |
+, low risk of bias; −, high risk of bias; ?, unclear risk of bias.
*Newcastle-Ottawa Scale.
†STROBE quality assessment tool.
‡Eide et al30 only recruited nulliparous women.
EPOC, Effective Practice and Organisation of Care group; NA, not applicable; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology.